生物科技高階管理碩士專班

Medicine & Life Sciences

1. 15,16-dihydrotanshinone I 14%
2. 15-deoxy-delta(12,14)-prostaglandin J2 19%
3. alkannin 28%
4. Antihypertensive Agents 14%
5. Antioxidants 15%
6. Apoptosis 33%
7. Appendectomy 14%
8. Bariatric Surgery 42%
9. Bariatrics 12%
10. Bibliometrics 19%
11. Bispecific Antibodies 12%
12. Blood Pressure 15%
13. Body Mass Index 18%
14. Breast Neoplasms 12%
15. Case-Control Studies 23%
16. Cell Movement 31%
17. Cell Proliferation 13%
18. Chitosan 15%
19. Chronic Renal Insufficiency 20%
20. Cohort Studies 55%
21. Colon 12%
22. Colonic Neoplasms 25%
23. Colorectal Neoplasms 24%
24. Comorbidity 12%
25. Confidence Intervals 58%
26. Costs and Cost Analysis 12%
27. Data Mining 15%
28. Databases 21%
29. Delivery of Health Care 22%
30. Dioscorea 32%
31. Down-Regulation 15%
32. Dry Eye Syndromes 12%
33. Elderly 21%
34. Endothelial Cells 11%
35. Gallbladder Diseases 14%
36. Gastrectomy 27%
37. Gastric Bypass 27%
38. Gene Expression 15%
39. Genes 20%
40. Genistein 12%
41. Glucose 12%
42. glucose-regulated proteins 15%
43. Growth 12%
44. Health 22%
45. Health Expenditures 12%
46. Health Literacy 13%
47. Hepatocellular Carcinoma 27%
48. High Fat Diet 15%
49. HL-60 Cells 12%
50. In Vitro Techniques 19%
51. JNK Mitogen-Activated Protein Kinases 18%
52. Kenya 12%
53. Kidney Diseases 12%
54. Laparoscopy 17%
55. Latent Class Analysis 11%
56. Lipopolysaccharides 13%
57. Liposomes 13%
58. Liver 16%
59. Liver Cirrhosis 14%
60. Liver Neoplasms 13%
61. Logistic Models 18%
62. Macrophages 13%
63. Methanol 15%
64. Mitral Valve Prolapse 14%
65. Morbid Obesity 14%
66. Mortality 35%
67. National Health Programs 35%
68. Neoplasms 44%
69. Nicotinic Receptors 11%
70. Nitric Oxide 15%
71. Obesity 16%
72. Odds Ratio 38%
73. Osteoblasts 18%
74. osthol 23%
75. Parkinson Disease 11%
76. Peroxisome Proliferator-Activated Receptors 23%
77. Phosphorylation 15%
78. Phosphotransferases 11%
79. Physicians 14%
80. Polygonum 11%
81. Population 40%
82. Propensity Score 46%
83. Proteins 23%
84. Randomized Controlled Trials 14%
85. Rectal Neoplasms 14%
86. Retrospective Studies 22%
87. sanguinarine 11%
88. shikonin 23%
89. Squamous Cell Carcinoma 18%
90. Stomach 23%
91. Stomach Neoplasms 18%
92. Stroke 19%
93. Taiwan 100%
94. Therapeutics 16%
95. Triple Negative Breast Neoplasms 12%
96. Type 2 Diabetes Mellitus 12%
97. Vitis 14%
98. Weight Loss 28%
99. WJ1376-1 17%
100. WJ1398-1 17%

Chemical Compounds

1. 1,2-dioxane 6%
2. Alkannin 25%
3. Alloy 12%
4. Antidiabetic Agent 10%
5. Antigen 5%
6. Antihypertensive 9%
7. Antioxidant Agent 16%
8. Antitumor 5%
9. Apoptotic 18%
10. Application 5%
11. Aristolochic Acid 5%
12. Bioceramic 8%
13. Blood Pressure 13%
14. Cabozantinib 7%
15. Cantharidin 6%
16. Chitosan 11%
17. Cytometry 5%
18. Decomposition 5%
19. Dextromethorphan 5%
20. Dipeptide 7%
21. Disorder 8%
22. Dose 5%
23. Drug 12%
24. Econazole 6%
25. Embossing 5%
26. Enantiomer 8%
27. Fluidization 9%
28. Fluorometholone 6%
29. Galactose 5%
30. Genotoxicity 8%
31. Geraniin 6%
32. Glucose 16%
33. Glycine Hydroxamate 7%
34. Griseofulvin 5%
35. Growth Factor 8%
36. Heme 6%
37. Hemodynamic 5%
38. Hydrocarbon 5%
39. Hypercholesterolemic 5%
40. Hypertensive 10%
41. Implant 9%
42. Irinotecan 5%
43. Isoorientin 5%
44. Ligand 5%
45. Lipopolysaccharide 9%
46. Liposome 10%
47. Machining 8%
48. Magnolol 5%
49. Methanol 9%
50. Miconazole 5%
51. Microstructure 5%
52. Nanocarrier 11%
53. Naphthazarin 5%
54. Nitric Oxide 10%
55. Osthole 24%
56. Permeability 5%
57. Photooxidation 5%
58. Plasma 8%
59. Podophyllotoxin 5%
60. Poly(I:C) 5%
61. Propofol 5%
62. Protein 25%
63. Quercetin 5%
64. Reactive Oxygen Metabolite 5%
65. Resveratrol 11%
66. Retinal 6%
67. Rosiglitazone 5%
68. Shikonin 23%
69. Sinapic Acid 5%
70. Surface 10%
71. Surface Damage 10%
72. Terbinafine 5%
73. Terfenadine 5%
74. Thrombin 5%
75. Time 8%
76. Triglyceride 6%
77. Water Soluble 5%
78. Weight 8%